Risk factors for ICU-acquired imipenem-resistant Gram-negative bacterial infections

Journal of Hospital Infection

Volumn 59, Issue 4, 2005, Pages 317-323

  Akinci, Esragul ^a,b   Colpan A ^a   Bodur, H ^a   Balaban, N ^a   Erbay, A ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Acinetobacter; Antibiotic resistance; Imipenem; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AMPICILLIN; CARBAPENEM; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOTETAN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TOBRAMYCIN;

ACINETOBACTER; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATION; CASE CONTROL STUDY; CORRELATION ANALYSIS; DRUG EXPOSURE; FEMALE; FISHER EXACT TEST; GRAM NEGATIVE INFECTION; HIGH RISK PATIENT; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; MULTIVARIATE ANALYSIS; POSTOPERATIVE INFECTION; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SEPSIS; STATISTICAL ANALYSIS; STUDENT T TEST; SURGICAL TECHNIQUE; TURKEY (REPUBLIC); URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IMIPENEM; INFECTION CONTROL; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND INFECTION; TURKEY;

EID: 14744293382     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2004.09.030     Document Type: Article

References (33)

1. A.C. Gales R.N. Jones K.R. Forward J. Linares H.S. Sader J. Verhoef Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999) Clin Infect Dis 32 Suppl. 2 2001 S104-S113
2. J. Ruiz M.L. Nunez J. Perez E. Simarro L. Martinez-Campos J. Gomez Evolution of resistance among clinical isolates of Acinetobacter over a 6-year period Eur J Clin Microbiol Infect Dis 18 1999 292-295
3. H.C. Neu Resistance of Pseudomonas aeruginosa to imipenem Infect Control Hosp Epidemiol 13 1992 7-9
4. R.P. Gaynes D.H. Culver Resistance to imipenem among selected Gram-negative bacilli in the United States Infect Control Hosp Epidemiol 13 1992 10-14
5. H.S. Sader A.C. Pignatari I.L. Leme et al. Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit Diagn Microbiol Infect Dis 17 1993 13-18
6. A.S. Levin C.M. Mendes S.I. Sinto et al. An outbreak of multiresistant Acinetobacter baumanii in a university hospital in Sao Paulo, Brazil Infect Control Hosp Epidemiol 17 1996 366-368
7. J.P. Quinn A.E. Studemeister C.A. DiVincenzo S.A. Lerner Resistance to imipenem in Pseudomonas aeruginosa: Clinical experience and biochemical mechanisms Rev Infect Dis 10 1988 892-898
8. S. Satake H. Yoneyama T. Nakae Role of OmpD2 and chromosomal beta-lactamase in carbapenem resistance in clinical isolates of Pseudomonas aeruginosa J Antimicrob Chemother 28 1991 199-207
9. D.M. Livermore Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa Antimicrob Agents Chemother 36 1992 2046-2048
10. K. Bush Metallo-beta lactamases: A class apart Clin Infect Dis 27 Suppl. 1 1998 S48-S53
11. K. Senda Y. Arakawa K. Nakashima et al. Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems Antimicrob Agents Chemother 40 1996 349-353
12. M. Watanabe S. Iyobe M. Inoue S. Mitsuhashi Transferable imipenem resistance in Pseudomonas aeruginosa Antimicrob Agents Chemother 35 1991 147-151
13. G. Cornaglia A. Mazzariol L. Lauretti G.M. Rossolini R. Fontana Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase Clin Infect Dis 31 2000 1119-1125
14. L. Lauretti M.L. Riccio A. Mazzariol et al. Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate Antimicrob Agents Chemother 43 1999 1584-1590
15. N. Woodford M.F. Palepou G.S. Babini J. Bates D.M. Livermore Carbapenemase-producing Pseudomonas aeruginosa in UK Lancet 352 1998 546-547
16. O. Cardoso J.C. Sousa R. Leitao L. Peixe Carbapenem-hydrolysing beta-lactamase from clinical isolates of Pseudomonas aeruginosa in Portugal J Antimicrob Chemother 44 1999 135
17. A. Tsakris S. Pournaras N. Woodford et al. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece J Clin Microbiol 38 2000 1290-1292
18. R.B. Clark Imipenem resistance among Acinetobacter baumannii: association with reduced expression of a 33-36 kDa outer membrane protein J Antimicrob Chemother 38 1996 245-251
19. M. Gehrlein H. Leying W. Cullmann S. Wendt W. Opferkuch Imipenem resistance in Acinetobacter baumanii is due to altered penicillin-binding proteins Chemotherapy 37 1991 405-412
20. G.J. Da Silva G.J. Leitao L. Peixe Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates J Clin Microbiol 37 1999 2109-2110
21. G. Bou G. Cervero M.A. Dominguez C. Quereda J. Martinez-Beltran Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases J Clin Microbiol 38 2000 3299-3305
22. A. Takahashi S. Yomoda I. Kobayashi T. Okubo M. Tsunoda S. Iyobe Detection of carbapenemase-producing Acinetobacter baumannii in a hospital J Clin Microbiol 38 2000 526-529
23. W.A. Knaus E.A. Draper D.P. Wagner J.E. Zimmerman APACHE II: A severity of disease classification system Crit Care Med 13 1985 818-829
24. J.S. Garner W.R. Jarvis T.G. Emori T.C. Horan J.M. Hughes CDC definitions for nosocomial infections Am J Infect Control 16 1988 128-140
25. N. Troillet M.H. Samore Y. Carmeli Imipenem-resistant Pseudomonas aeruginosa: Risk factors and antibiotic susceptibility patterns Clin Infect Dis 25 1997 1094-1098
26. A.D. Harris D. Smith J.A. Johnson D.D. Bradham M.C. Roghmann Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients Clin Infect Dis 34 2002 340-345
27. J.F. Acar Therapy for lower respiratory tract infections with imipenem/ cilastatin: A review of worldwide experience Rev Infect Dis 7 Suppl. 3 1985 S513-S517
28. R.A. Salata R.L. Gebhart D.L. Palmer et al. Pneumonia treated with imipenem/cilastatin JAMA 78 Suppl. 6A 1985 S96-S102
29. M.J. Lynch G.L. Drusano H.L. Mobley Emergence of resistance to imipenem in Pseudomonas aeruginosa Antimicrob Agents Chemother 31 1987 1892-1896
30. H. Stephan D.H. Anthony C. Yehuda H.S. Matthew Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in Gram-negative bacilli Clin Infect Dis 33 2001 1462-1468
31. J.P. Quinn E.J. Dudek C.A. DiVincenzo D.A. Lucks S.A. Lerner Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections J Infect Dis 154 1986 289-294
32. A.S. Levin A.A. Barone J. Penco et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clin Infect Dis 28 1999 1008-1011
33. X. Corbella J. Ariza C. Ardanuy et al. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii J Antimicrob Chemother 42 1998 793-802